Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients...
Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma
About this item
Full title
Author / Creator
Tokyo Metropolitan Innovative Oncology Research Group (TMIG) , the Tokyo Metropolitan Innovative Oncology Research Group (TMIG) , Ura, Ayako , Hayashi, Takuo , Komura, Kazumasa , Hosoya, Masaki , Takamochi, Kazuya , Sato, Eiichi , Saito, Satomi , Wakai, Susumu , Handa, Takafumi , Saito, Tsuyoshi , Kato, Shunsuke , Suzuki, Kenji and Yao, Takashi
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
A limited number of patients with lung squamous cell carcinoma (SCC) benefit clinically from molecular targeted drugs because of a lack of targetable driver alterations. We aimed to understand the prevalence and clinical significance of lysine‐specific demethylase 5D (KDM5D) copy number loss in SCC and explore its potential as a predictive biomarke...
Alternative Titles
Full title
Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma
Authors, Artists and Contributors
Author / Creator
the Tokyo Metropolitan Innovative Oncology Research Group (TMIG)
Ura, Ayako
Hayashi, Takuo
Komura, Kazumasa
Hosoya, Masaki
Takamochi, Kazuya
Sato, Eiichi
Saito, Satomi
Wakai, Susumu
Handa, Takafumi
Saito, Tsuyoshi
Kato, Shunsuke
Suzuki, Kenji
Yao, Takashi
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d74d3a6bf28241e39e1c5855f8cdaf80
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d74d3a6bf28241e39e1c5855f8cdaf80
Other Identifiers
ISSN
2056-4538
E-ISSN
2056-4538
DOI
10.1002/cjp2.350
